| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 30/09/2024 | 22:05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 06/09/2024 | 23:17 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 19/08/2024 | 23:20 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 17/07/2024 | 18:32 | Edgar (US Regulatory) | Form 8-K - Current report | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 07/06/2024 | 23:28 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 27/02/2024 | 19:42 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 05/05/2023 | 22:43 | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 03/04/2023 | 19:06 | Edgar (US Regulatory) | Notification That Annual Report Will Be Submitted Late (nt 10-k) | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 28/03/2023 | 23:37 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 06/12/2022 | 23:30 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 15/11/2022 | 23:23 | Edgar (US Regulatory) | Notification That Quarterly Report Will Be Submitted Late (nt 10-q) | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 16/08/2022 | 00:08 | Edgar (US Regulatory) | Quarterly Report (10-q) | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 12/08/2021 | 14:34 | InvestorsHub NewsWire | Pressure BioSciences New Eco-Friendly Agrochem Subsidiary Receives Over $1,000,000 in Orders in First Month of Operations | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 05/08/2021 | 14:13 | InvestorsHub NewsWire | Pressure BioSciences Unveils Aggressive Growth Plan and Goals for Second Half 2021; Company Marches Toward UST Commercial Release, Up-listing, and Profitability | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 30/07/2021 | 20:54 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 21/07/2021 | 15:46 | InvestorsHub NewsWire | Pressure BioSciences Announces Major Business Expansion, Establishing Eco-Friendly Agrochemicals Subsidiary and Initiating Plans to Drive Accretive 2021 Revenue | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 16/07/2021 | 20:44 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 01/07/2021 | 14:14 | InvestorsHub NewsWire | Pressure BioSciences Novel UST™ Platform Delivers Breakthrough Nanoemulsion Processing for One of the World's Most ..cont | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 15/04/2021 | 23:31 | Edgar (US Regulatory) | Annual Report (10-k) | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 20/01/2021 | 15:18 | InvestorsHub NewsWire | Pressure BioSciences Ultra Shear Technology Nanoemulsions Platform Targets Revolution in Effectiveness of Therapeutics via | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 17/12/2020 | 15:00 | InvestorsHub NewsWire | Pressure BioSciences PCT Platform at Forefront in Generating Pivotal Findings by Diverse COVID-19 Research Teams | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 15/12/2020 | 16:19 | InvestorsHub NewsWire | Pressure BioSciences to Present at Upcoming Life Sciences Investor Forum | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 17/11/2020 | 17:12 | InvestorsHub NewsWire | Pressure BioSciences, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 16/11/2020 | 21:20 | InvestorsHub NewsWire | Pressure BioSciences, Inc. to Discuss Third Quarter 2020 Financial Results and Provide Business Update | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 11/11/2020 | 16:38 | InvestorsHub NewsWire | Pressure BioSciences Awarded First U.S. Patent for Revolutionary Ultra Shear Technology Platform | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 11/06/2020 | 15:00 | InvestorsHub NewsWire | $3,500,000 Initial Order for FDA-Registered, Premium Hand Sanitizer Catapults SkinScience Labs, a Pending Accretive Acquisition | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 28/05/2020 | 15:39 | InvestorsHub NewsWire | Pressure BioSciences Announces Launch of Novel, FDA Registered Immune Booster by Pending Merger Partner Cannaworx, Inc. | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 14/05/2020 | 14:45 | InvestorsHub NewsWire | Pressure BioSciences Announces Launch of FDA-Registered Hand Sanitizer as First Product Developed Through Pending Merger Part... | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 07/05/2020 | 14:45 | InvestorsHub NewsWire | Former L'Oréal President Jim Morrison Appointed as CEO To Lead Availa Bio Upon Merger of Pressure BioSciences | USOTC:PBIO | Pressure Biosciences Inc (CE) |
| 05/05/2020 | 15:39 | InvestorsHub NewsWire | Pressure BioSciences Announces Planned Name Change to "Availa Bio" Following Completion of Cannaworx and SkinScience Labs | USOTC:PBIO | Pressure Biosciences Inc (CE) |